Nanotechnology as a tool to advance research and treatment of non-oncologic urogenital diseases

Nanotechnology represents an expanding area of research and innovation in almost every field of science, including Medicine, where nanomaterial-based products have been developed for diagnostic and therapeutic applications. Because of their small, nanoscale size, these materials exhibit unique physi...

Full description

Bibliographic Details
Main Authors: Justin Loloi, Mustufa Babar, Kelvin P. Davies, Sylvia O. Suadicani
Format: Article
Language:English
Published: SAGE Publishing 2022-07-01
Series:Therapeutic Advances in Urology
Online Access:https://doi.org/10.1177/17562872221109023
_version_ 1811312303147057152
author Justin Loloi
Mustufa Babar
Kelvin P. Davies
Sylvia O. Suadicani
author_facet Justin Loloi
Mustufa Babar
Kelvin P. Davies
Sylvia O. Suadicani
author_sort Justin Loloi
collection DOAJ
description Nanotechnology represents an expanding area of research and innovation in almost every field of science, including Medicine, where nanomaterial-based products have been developed for diagnostic and therapeutic applications. Because of their small, nanoscale size, these materials exhibit unique physical and chemical properties that differ from those of each component when considered in bulk. In Nanomedicine, there is an increasing interest in harnessing these unique properties to engineer nanocarriers for the delivery of therapeutic agents. Nano-based drug delivery platforms have many advantages over conventional drug administration routes as this technology allows for local and transdermal applications of therapeutics that can bypass the first-pass metabolism, improves drug efficacy through encapsulation of hydrophobic drugs, and allows for a sustained and controlled release of encapsulated agents. In Urology, nano-based drug delivery platforms have been extensively investigated and implemented for cancer treatment. However, there is also great potential for use of nanotechnology to treat non-oncologic urogenital diseases. We provide an update on research that is paving the way for clinical translation of nanotechnology in the areas of erectile dysfunction (ED), overactive bladder (OAB), interstitial cystitis/bladder pain syndrome (IC/BPS), and catheter-associated urinary tract infections (CAUTIs). Overall, preclinical and clinical studies have proven the utility of nanomaterials both as vehicles for transdermal and intravesical delivery of therapeutic agents and for urinary catheter formulation with antimicrobial agents to treat non-oncologic urogenital diseases. Although clinical translation will be dependent on overcoming regulatory challenges, it is inevitable before there is universal adoption of this technology to treat non-oncologic urogenital diseases.
first_indexed 2024-04-13T10:34:50Z
format Article
id doaj.art-819f595d65c74e659ff7a8dbd22d57fb
institution Directory Open Access Journal
issn 1756-2880
language English
last_indexed 2024-04-13T10:34:50Z
publishDate 2022-07-01
publisher SAGE Publishing
record_format Article
series Therapeutic Advances in Urology
spelling doaj.art-819f595d65c74e659ff7a8dbd22d57fb2022-12-22T02:50:05ZengSAGE PublishingTherapeutic Advances in Urology1756-28802022-07-011410.1177/17562872221109023Nanotechnology as a tool to advance research and treatment of non-oncologic urogenital diseasesJustin LoloiMustufa BabarKelvin P. DaviesSylvia O. SuadicaniNanotechnology represents an expanding area of research and innovation in almost every field of science, including Medicine, where nanomaterial-based products have been developed for diagnostic and therapeutic applications. Because of their small, nanoscale size, these materials exhibit unique physical and chemical properties that differ from those of each component when considered in bulk. In Nanomedicine, there is an increasing interest in harnessing these unique properties to engineer nanocarriers for the delivery of therapeutic agents. Nano-based drug delivery platforms have many advantages over conventional drug administration routes as this technology allows for local and transdermal applications of therapeutics that can bypass the first-pass metabolism, improves drug efficacy through encapsulation of hydrophobic drugs, and allows for a sustained and controlled release of encapsulated agents. In Urology, nano-based drug delivery platforms have been extensively investigated and implemented for cancer treatment. However, there is also great potential for use of nanotechnology to treat non-oncologic urogenital diseases. We provide an update on research that is paving the way for clinical translation of nanotechnology in the areas of erectile dysfunction (ED), overactive bladder (OAB), interstitial cystitis/bladder pain syndrome (IC/BPS), and catheter-associated urinary tract infections (CAUTIs). Overall, preclinical and clinical studies have proven the utility of nanomaterials both as vehicles for transdermal and intravesical delivery of therapeutic agents and for urinary catheter formulation with antimicrobial agents to treat non-oncologic urogenital diseases. Although clinical translation will be dependent on overcoming regulatory challenges, it is inevitable before there is universal adoption of this technology to treat non-oncologic urogenital diseases.https://doi.org/10.1177/17562872221109023
spellingShingle Justin Loloi
Mustufa Babar
Kelvin P. Davies
Sylvia O. Suadicani
Nanotechnology as a tool to advance research and treatment of non-oncologic urogenital diseases
Therapeutic Advances in Urology
title Nanotechnology as a tool to advance research and treatment of non-oncologic urogenital diseases
title_full Nanotechnology as a tool to advance research and treatment of non-oncologic urogenital diseases
title_fullStr Nanotechnology as a tool to advance research and treatment of non-oncologic urogenital diseases
title_full_unstemmed Nanotechnology as a tool to advance research and treatment of non-oncologic urogenital diseases
title_short Nanotechnology as a tool to advance research and treatment of non-oncologic urogenital diseases
title_sort nanotechnology as a tool to advance research and treatment of non oncologic urogenital diseases
url https://doi.org/10.1177/17562872221109023
work_keys_str_mv AT justinloloi nanotechnologyasatooltoadvanceresearchandtreatmentofnononcologicurogenitaldiseases
AT mustufababar nanotechnologyasatooltoadvanceresearchandtreatmentofnononcologicurogenitaldiseases
AT kelvinpdavies nanotechnologyasatooltoadvanceresearchandtreatmentofnononcologicurogenitaldiseases
AT sylviaosuadicani nanotechnologyasatooltoadvanceresearchandtreatmentofnononcologicurogenitaldiseases